SpeedWeed

AUGUST 4, 2021

Medical Cannabis Australia, the company she founded, just obtained its cultivation and manufacture licenses from the Office of Drug Control (ODC) in April of this year. With our state-of-the-art greenhouse technology, we can duplicate the exact growing environment for our plants, crop after crop (i.e.,

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

Cannabis Law Report

JANUARY 6, 2022

NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today the appointment of accomplished business leader and cannabis industry expert Tim Leslie as the Chairman of its newly formed Advisory Board. “I Forward-looking statements are only predictions.

Research and Development 52

Research and Development Events Clinical Trials Business 52

Cannabis Law Report

JULY 4, 2019

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer. About EMMAC.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

The Cannigma

DECEMBER 12, 2022

They do carry the risk of a “bad trip,” in which anxiety, confusion and unpredictable behavior can be potentially dangerous in the wrong environment. Making sure you have the proper set (the state of your mind) and setting (your environment) is important to minimize these risks.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

DECEMBER 22, 2019

Australian marijuana stocks have cratered and work on one huge growing project is on hold, but three other big cannabis cultivation projects are pushing onwards, raising the prospect of oversupply and an eventual shakeout in the industry, one expert says. Here’s the story about these unicorn like grow projects. Yahoo News reports.

Clinical Trials 59

Clinical Trials Cannabis Environment Pharmaceutical 59

Cannabis Law Report

SEPTEMBER 3, 2019

MediPharm Labs Australia has also successfully negotiated multi-year supply agreements with three Australian Office of Drug Control (“ODC”) approved cultivators (including BBS Pharmaceuticals). This input supply will support the extraction and production of private label oil in Australia for local and international markets.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Cannabis Law Report

APRIL 8, 2019

We also consider some of the issues associated with regulatory environment for medicinal cannabis in Australia. Between November 2016 and 15 January 2019, the Office of Drug Control (ODC) has granted a total of 26 medicinal cannabis (cultivation and production) and 20 manufacturing licences. Chapter 2 of the NDA.

Medicine 71

Medicine Research and Development Business Cannabis 71

Cannabis Law Report

SEPTEMBER 1, 2019

By early 2016, Australia’s federal parliament passed a bill that laid the groundwork for cannabis to be legally cultivated and manufactured for medicinal and scientific purposes here. We found the environment to be positive and supportive.”. The clinical trials and the standard of production could lead the world.”.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

Cannabis Law Report

DECEMBER 20, 2021

It is also called industrial hemp , plant of the family Cannabaceae cultivated for its bast fibre or its edible seeds 1. Since only three states have started granting licenses for the cultivation of cannabis, it is not clear to whom the application shall be made in other states. Regulation 2.16. Footnotes.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

Cannabis Law Report

SEPTEMBER 21, 2021

Hunter Neubauer, Co-Founder and Chairman of the Board at Oregrown, is a passionate and multifaceted leader focused on expanding Oregrown’s wholesale and distribution capabilities, cultivation efficiencies and business development opportunities. Historically, getting a license approval or transfer could take years. Are discussions happening?

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

Cannabis Law Report

OCTOBER 3, 2019

The Australian Capital Territory ( ACT ) voted to legalise the personal possession and cultivation of cannabis. The ACT Legislative Assembly voted to legalise the personal possession and cultivation of cannabis on 25 September 2019. Final Report Reviewing Framework for Medicinal Cannabis Cultivation, Production and Manufacture.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40

Cannabis Law Report

JULY 15, 2022

The first Australian company to be licensed to cultivate and manufacture medicinal marijuana has praised the Federal Government’s plan to allow exports of cannabis-based medicines. “We cultivate, we produce, we manufacture, we bottle and then we distribute onsite, which I think for accountability is very important.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

JANUARY 18, 2019

iCAN is committed to accelerate Israel’s Canna-Technology industry, capitalizing on Israeli innovation and a leading cannabis regulatory environment to bring premier products to market. Several of these products have already completed or been approved for clinical trials in Israel. About iCAN: Israel-Cannabis.

Research and Development 40

Research and Development Clinical Trials Extraction Therapy 40

Cannabis Law Report

AUGUST 12, 2019

There are two main species of cannabis that are cultivated for human consumption, namely Cannabis indica and Cannabis sativa. Sativa plants are taller and produce more fiber and are therefore the species from which hemp cultivation arose. It is cultivated mainly for medicinal and “recreational” purposes. However, many U.S.

CBD 40

CBD Terpenes Oil Tincture 40

Cannabis Law Report

OCTOBER 17, 2019

As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. CBD candles and outdoor grow lights for home cultivation) are expected to embrace cannabis to various degrees.

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

SEPTEMBER 20, 2019

But at the Vegas event, she brought good news: She announced that other universities would host her research, and she recently applied for a third-party cultivation license from the DEA, the only federal agency that can legally provide cannabis for clinical study in the US. What can cultivation applicants such as Dr. Sisley do now?

DEA 228

DEA Research and Development Clinical Trials Patients 228